Strain-specific viral distribution and neuropathology of feline immunodeficiency virus

Veterinary Immunology and Immunopathology

Volumn 143, Issue 3-4, 2011, Pages 282-291

  Miller, Craig ^a   Bielefeldt Ohmann, Helle ^b   MacMillan, Martha ^a   Huitron Resendiz, Salvador ^c   Henriksen, Steven ^d   Elder, John ^c   VandeWoude, Susan ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Feline immunodeficiency virus; Lentiviral neuropathology; NeuroAIDS

Indexed keywords

CASPASE 3; SYNAPTOPHYSIN; VASCULOTROPIN; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CORTEX; CAUDATE NUCLEUS; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; ENCEPHALITIS; EVOKED BRAIN STEM AUDITORY RESPONSE; FELINE IMMUNODEFICIENCY VIRUS; HEMATOLOGY; INFLAMMATION; LENTIVIRUS INFECTION; LYMPHOCYTIC INFILTRATION; MENINGITIS; MICROGLIA; NERVE CELL DEGENERATION; NERVE CONDUCTION; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NERVE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; BRAIN; BRAIN STEM; CATS; CENTRAL NERVOUS SYSTEM; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GENE PRODUCTS, GAG; IMMUNODEFICIENCY VIRUS, FELINE; MAGNETIC RESONANCE IMAGING; RNA, VIRAL; VIRAL LOAD;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; PRIMATES;

EID: 80052368564     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.06.006     Document Type: Article

References (52)

1. Bell J.E. The neuropathology of adult HIV infection. Rev. Neurol. (Paris) 1998, 154:816-829.
2. Bielefeldt-Ohmann H., Tolnay A.E., Reisenhauer C.E., Hansen T.R., Smirnova N., Van Campen H. Transplacental infection with non-cytopathic bovine viral diarrhoeavirus types 1b and 2: viral spread and molecular neuropathology. J. Comp. Pathol. 2008, 138:72-85.
3. Bucy, D.S., Bielefeldt-Ohmann, H., Thompson, J., Bachand, A., Brown, M.S., Morges, M., Elder, J.H., VandeWoude, S., Kraft, S. Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection. AIDS, in press.
4. Dallasta L.M., Pisarov L.A., Esplen J.E., Werley J.V., Moses A.V., Nelson J.A., Achim C.L. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 1999, 155:1915-1927.
5. de Rozieres S., Mathiason C.K., Chatterji U., Rolston U., Hoover E.A., Elder J.H. Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C. J. Virol. 2004, 78:8971-8982.
6. de Rozieres S., Swan C.H., Sheeter D.A., Clingerman K.J., Lin Y.C., Huitron-Resendiz S., Henriksen S., Torbett B.E., Elder J.H. Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3. Retrovirology 2004, 1:38.
7. de Rozieres S., Thompson J., Sundstrom M., Gruber J., Stump D.S., de Parseval A.P., VandeWoude S., Elder J.H. Replication properties of clade a/c chimeric feline immunodeficiency viruses and evaluation of infection kinetics in the domestic cat. J. Virol. 2008, 82:7953-7963.
8. Diehl L.J., Mathiason-Dubard C.K., O'Neil L.L., Obert L.A., Hoover E.A. Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage. J. Virol. 1995, 67:5175-5186.
9. Eggert D., Dash P.K., Serradji N., Dong C.Z., Clayette P., Heymans F., Dou H., Gorantla S., Gelbard H.A., Poluektova L., Gendelman H.E. Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders. J. Neuroimmunol. 2009, 213:47-59.
10. Everall I., Gray F., Barnes H., Durigon M., Luthert P., Lantos P. Neuronal loss in symptom-free HIV infection. The Lancet 1995, 340:1413-11413.
11. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
12. Fletcher N.F., Brayden D.J., Brankin B., Callanan J.J. Feline immunodeficiency virus infection: a valuable model to study HIV-1 associated encephalitis. Vet. Immunol. Immunopathol. 2008, 123(1-2):134-137.
13. Gonzalez-Scarano F., Martin-Garcia J. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 2005, 5:69-81.
14. Gray F., Hurtrel M., Hurtrel B. Early central nervous system changes in human immunodeficiency virus (HIV)-infection. Neuropathol. Appl. Neurobiol. 1996, 19:3-9.
15. Gong Y.F., Robinson B.S., Rose R.E., Deminie C., Spicer T.P., Stock D., Colonno R.J., Lin P.F. In vitro resistance profile of the human immunodeficiency virus type I protease inhibitor BMS-232632. Antimicrob. Agents Chemother. 2000, 44:2319-2326.
16. Herlaar E., Brown Z. p38 MAPK signaling cascades in inflammatory disease. Mol. Med. Today 1999, 5:439-447.
17. Huitron-Resendiz S., de Rozieres S., Sanchez-Alavez M., Buhler B., Lin Y.C., Lerner D.L., Henriksen N.W., Burudi M., Fox H.S., Torbett B.E., Henriksen S., Elder J.H. Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3. J. Virol. 2004, 78:4525-4532.
18. Kramer-Hammerle S., Rothenaigner I., Wolff H., Bell J.E., Brack-Werner R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 2005, 111:194-213.
19. Lendhardt T., Super M., Wiley C. Neuropathological changes in an asymptomatic HIV seropositive man. Ann. Neurol. 1988, 23:209-210.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCTmethod. Methods 2001, 25:402-408.
21. Luabeya M.K., Dallasta L.M., Achim C.L., Puaza C.D., Hamilton R.L. Blood-brain barrier disruption in simian immunodeficiency virus encephalitis. Neuropathol. Appl. Neurobiol. 2000, 26:454-462.
22. Matas C.G., Silva S.M., Marcon Bde A., Gonçalves I.C. Electrophysiological manifestations in adults with HIV/AIDS submitted and not submitted to antiretroviral therapy. Pro Fono 2010, 22(2):107-113.
23. Meeker R.B., Thiede B.A., Hall C., English R., Tompkins M. Cortical cell loss in asymptomatic cats experimentally infected with feline immunodeficiency virus. AIDS Res. Human Retrov. 1997, 13:1131-1140.
24. Meeker R.B. Feline immunodeficiency virus neuropathogenesis: from cats to calcium. J. Neuroimmune Pharmacol. 2007, 2:154-170.
25. Melcher J.R., Knudson I.M., Fullerton B.C., Guinan J.J., Norris B.E., Kiang N.Y. Generators of the brainstem auditory evoked potential in cat. I. An experimental approach to their identification. Hear. Res. 1996, 93:1-27.
26. Melcher J.R., Guinan J.J., Knudson I.M., Kiang N.Y. Generators of the brainstem auditory evoked potential in cat II. Correlating lesion sites with waveform changes. Hear. Res. 1996, 93:28-51.
27. Melcher J.R., Kiang N.Y. Generators of the brainstem auditory evoked potential in cat III: identified cell populations. Hear. Res. 1996, 93:52-71.
28. Obert L.A., Hoover E.A. Feline immunodeficiency virus clade C mucosal transmission and disease courses. AIDS Res. Hum. Retrovir. 2000, 16:677-688.
29. Ollo C., Johnson R., Grafman J. Signs of cognitive change in HIV disease: an event-related brain potential study. Neurology 1991, 41:209-215.
30. Phillips T.R., Talbott R.L., Lamont C., Muir S., Lovelace K., Elder J.H. Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 1990, 64:4605-4613.
31. Phillips T.R., Prospero-Garcia O., Puaoi D.L., Lerner D.L., Fox H.S., Olmsted R.A., Bloom F.E., Henriksen S.J., Elder J.H. Neurological abnormalities associated with feline immunodeficiency virus infection. J. Gen. Virol. 1994, 75:979-987.
32. Phillips T.R., Prospero-Garcia O., Wheeler D.W., Wagaman P.C., Lerner D.L., Fox H.S., Whalen L.R., Bloom F.E., Elder J.H., Henriksen S.J. Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J. Neurovirol. 1996, 2:388-396.
33. Phipps A., Hayes K., Podell M., Buck W., Mathes L. Disease progression following feline immunodeficiency virus molecular clone FIV-PPR DNA inoculation. J. AIDS Hum. Retrovirol. 2000, 23:8-16.
34. Podell M., Oglesbee M., Mathes L., Krakowka S., Olmsted R., Lafrado L. AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection. J. AIDS Hum. Retrovirol. 1993, 6:758-771.
35. Podell M., Hayes K., Oglesbee M., Mathes L. Progressive encephalopathy associated with CD4/CD8 inversion in adult FIV-infected cats. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1997, 15:332-340.
36. Podell M., March P.A., Buck W.R., Mathes L.E. The feline model of neuroAIDS: understanding the progression towards AIDS dementia. J. Psycopharmacol. 2000, 14:205-213.
37. Podell M., Maruyama K., Smith M., Hayes K., Buck W.R., Ruehlmann D., Mathes L. Frontal lobe injury correlates to altered function in FIV-infected cats. J. AIDS Hum. Retrovirol. 1999, 22:10-18.
38. Poli A., Pistello M., Carli M.A., Abramo F., Mancuso G., Nicoletti E., Bendinelli M. Tumor necrosis factor-alpha and virus expression in the central nervous system of cats infected with feline immunodeficiency virus. J. Neurovirol. 1999, 5:465-473.
39. Porter A.G., Jänicke R.U. Emergingroles of caspases-3 in apoptosis. CellDeath Diff. 1999, 6:99-104.
40. Power C., Buist R., Johnston B., Del Bigio M.R., Ni W., Dawood M.R., Peeling J. Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression. J. Virol. 1998, 72:1175-1185.
41. Prospéro-García O., Herold N., Phillips T.R., Elder J.H., Bloom F.E., Henriksen S.J. Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc. Natl. Acad. Sci. 1994, 91:12947-12951.
42. Ryan G., Grimes T., Brankin B., Mabruk M.J., Hosie M.J., Jarrett O., Callanan J.J. Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers. J. Neurovirol. 2005, 11:337-345.
43. Samuelsson K., Pirskanen-Matell R., Bremmer S., Hindmarsh T., Nilsson B.Y., Persson H.E. The nervous system in early HIV infection: a prospective study through 7 years. Eur. J. Neurol. 2006, 13(3):283-291.
44. Siebelink K.H., Karlas J.A., Rimmelzwaan G.F., Osterhaus A.D., Bosch M.L. A determinant of feline immunodeficiency virus involved in Crandell feline kidney cell tropism. Vet. Immunol. Immunopathol. 1995, 46:61-69.
45. Sodora D.L., Shpaer E.G., Kitchell B.E., Dow S.W., Hoover E.A., Mullins J.I. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J. Virol. 1994, 68:2230-2238.
46. Thompson, J., 2009. Investigating molecular determinants of FIV pathogenesis. Unpublished Doctoral Dissertation. Colorado State University, Fort Collins, CO, USA.
47. Tolnay A.E., Baskin C.R., Tumpey T.M., Sabourin P.J., Sabourin C.L., Long J.P., Pyles J.A., Albrecht R.A., García-Sastre A., Katze M.G., Bielefeldt-Ohmann H. Extrapulmonarytissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus. Arch. Virol. 2010, 155:905-914.
48. Vahlenkamp T.W., de Ronde A., Schuurman N.N., van Vliet A.L., van Drunen J., Horzinek M.C., Egberink H.F. Envelope gene sequences encoding variable regions 3 and 4 are involved in macrophage tropism of feline immunodeficiency virus. J. Gen. Virol. 1999, 80(Pt 10):2639-2646.
49. Vahlenkamp T.W., Verschoor E.J., Schuurman N.N., van Vliet A.L., Horzinek M.C., Egberink H.F., de Ronde A. A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cell tropism. J. Virol. 1997, 71:7132-7135.
50. Verschoor E.J., Boven L.A., Blaak H., van Vliet A.L., Horzinek M.C., de Ronde A. A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells. J. Virol. 1995, 69:4752-4757.
51. Willet B.J., Picard L., Hosie M.J., Turner J.D., Adema K., Clapham P.R. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 1997, 71:6407-6415.
52. Zink M.C., Laast V.A., Helke K.L., Brice A.K., Barber S.A., Clements J.E., Mankowski J.L. From mice to macaques - animal models of HIV nervous system disease. Curr. HIV Res. 2006, 3:293-305.